Friday, April 22, 2022 3:16:18 PM
Recent OBSV News
- ObsEva Announces Delisting from SIX Swiss Exchange and Exemption from Certain Obligations Associated with the Maintenance of Listin • GlobeNewswire Inc. • 04/03/2024 05:00:00 AM
- ObsEva Announces Update on Board of Directors • GlobeNewswire Inc. • 03/19/2024 06:00:00 AM
- ObsEva Announces Wind-Down of Operations and Notifies SIX that it Will Lack the Resources to Establish Audited IFRS Financial Statements for 2023 • GlobeNewswire Inc. • 02/28/2024 06:00:00 AM
- Geneva Court Grants Temporary Moratorium to ObsEva • GlobeNewswire Inc. • 01/31/2024 06:00:00 AM
- ObsEva Announces Application for a Moratorium to Facilitate Pivotal Deals • GlobeNewswire Inc. • 11/30/2023 06:00:00 AM
- Organon Returns Ebopiprant to XOMA • GlobeNewswire Inc. • 10/27/2023 09:00:00 PM
- ObsEva Files half Year 2023 Financial Statements • GlobeNewswire Inc. • 09/27/2023 05:00:00 AM
- ObsEva Recovers Full Worldwide Rights on Nolasiban • GlobeNewswire Inc. • 07/13/2023 05:00:00 AM
- Annual General Meeting 2023 • GlobeNewswire Inc. • 06/08/2023 05:00:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM